Skip to main content
SpringerLink
Log in

Iron status during anti-TNF therapy in children with juvenile idiopathic arthritis

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Patients with active juvenile idiopathic arthritis (JIA) have frequently low haemoglobin (Hgb) due to inflammation and/or iron deficiency. The aim of the study was to evaluate the effect of anti-tumor necrosis factor (TNF) therapy on their iron status. Twenty children with JIA were treated with either etanercept (n = 8) or infliximab (n = 12) for 12 months. Iron status was assessed during anti-TNF treatment by Hgb, mean corpuscular volume of red blood cells (MCV), serum iron (sFe), ferritin, percent transferrin saturation (sTrfesat) and serum transferrin receptor concentration (sTfR). The sTfR/log ferritin index (TfR/logF) was also used. Prior to the therapy, Hgb and MCV were 118 ± 15.5 g/L and 79 ± 7.7 fl in the infliximab group, and 113 ± 12.5 g/L and 78 ± 5.8 fl in the etanercept group, respectively. In the whole group of patients, sFe was 6.3 ± 4.1 μmol/L and sTrfesat was 9% ± 6%. During anti-TNF therapy, Hgb and MCV improved significantly without use of iron supplementation, and sFe and sTrfesat increased from low to normal levels while inflammation markers decreased, except in one patient, in whom sTfR stayed elevated and the TfR/logF index value was high. In patients with active JIA associated with anaemia, low levels of sFe and sTrfesat cannot be used as markers for iron deficiency. In such patients, sTfR together with TfR/logF seem to be useful in assessing iron deficiency.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Kirel B, Yetgin S, Saatci U, Ozen S, Bakkaloglu A, Besbas N (1996) Anaemia in juvenile chronic arthritis. Clin Rheumatol 15:236–241

    Article  CAS  PubMed  Google Scholar 

  2. Papadaki HA, Kritikos HD, Valatas V, Boumpas DT, Eliopoulos GD (2002) Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy. Blood 100:474–482

    Article  CAS  PubMed  Google Scholar 

  3. Rusten LS, Jacobsen SE (1995) Tumor necrosis factor (TNF)-alpha directly inhibits human erythropoiesis in vitro: role of p55 and p75 TNF receptors. Blood 85:989–996

    CAS  PubMed  Google Scholar 

  4. Vreugdenhil G, Lowenberg B, Van Eijk HG, Swaak AJ (1992) Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis. Eur J Clin Investig 22:488–493

    Article  CAS  Google Scholar 

  5. Atkins MB, Kappler K, Mier JW, Isaacs RE, Berkman EM (1995) Interleukin-6-associated anemia: determination of the underlying mechanism. Blood 86:1288–1291

    CAS  PubMed  Google Scholar 

  6. Harvey AR, Pippard MJ, Ansell BM (1987) Microcytic anaemia in juvenile chronic arthritis. Scand J Rheumatol 16:53–59

    CAS  PubMed  Google Scholar 

  7. Minaur NJ, Jacoby RK, Cosh JA, Taylor G, Rasker JJ (2004) Outcome after 40 years with rheumatoid arthritis: a prospective study of function, disease activity, and mortality. J Rheumatol Suppl 69:3–8

    PubMed  Google Scholar 

  8. Cook JD (2005) Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol 18:319–332

    Article  CAS  PubMed  Google Scholar 

  9. Pettersson T, Kivivuori SM, Siimes MA (1994) Is serum transferrin receptor useful for detecting iron-deficiency in anaemic patients with chronic inflammatory diseases? Br J Rheumatol 33:740–744

    Article  CAS  PubMed  Google Scholar 

  10. Punnonen K, Kaipiainen-Seppanen O, Riittinen L, Tuomisto T, Hongisto T, Penttila L (2000) Evaluation of iron status in anemic patients with rheumatoid arthritis using an automated immunoturbidimetric assay for transferrin receptor. Clin Chem Lab Med 38:1297–1300

    Article  CAS  PubMed  Google Scholar 

  11. Zimmermann MB (2008) Methods to assess iron and iodine status. Br J Nutr 99:S2–S9

    Article  CAS  PubMed  Google Scholar 

  12. Skikne BS (2008) Serum transferrin receptor. Am J Hematol 83:872–875

    Article  CAS  PubMed  Google Scholar 

  13. Angeles Vázquez López M, Molinos FL, Carmona ML, Morales AC, Muñoz Vico FJ, Muñoz JL, Muñoz Hoyos A (2006) Serum transferrin receptor in children: usefulness for determinating the nature of anemia in infection. J Pediatr Hematol Oncol 28:809–815

    Article  PubMed  Google Scholar 

  14. Lahdenne P, Vahasalo P, Honkanen V (2003) Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study. Ann Rheum Dis 62:245–247

    Article  CAS  PubMed  Google Scholar 

  15. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J et al (2004) International League of Associations for Rheumatology. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392

    PubMed  Google Scholar 

  16. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A (1997) Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 40:1202–1209

    CAS  PubMed  Google Scholar 

  17. Labbé RF, Dewanji A (2004) Iron assessment tests: transferrin receptor vis-à-vis zinc protoporphyrin. Clin Biochem 37:165–174

    Article  PubMed  Google Scholar 

  18. Crowell R, Ferris AM, Wood RJ, Joyce P, Slivka H (2006) Comparative effectiveness of zinc protoporphyrin and hemoglobin concentrations in identifying iron deficiency in a group of low-income, preschool-aged children: practical implications of recent illness. Pediatrics 118:224–232

    Article  PubMed  Google Scholar 

  19. Suominen P, Punnonen K, Rajamaki A, Irjala K (1998) Serum transferrin receptor and transferrin receptor-ferritin index identify healthy subjects with subclinical iron deficits. Blood 92:2934–2939

    CAS  PubMed  Google Scholar 

  20. Puntarulo S (2005) Iron, oxidative stress and human health. Mol Aspects Med 26:299–312

    Article  CAS  PubMed  Google Scholar 

  21. Weiss G (2002) Pathogenesis and treatment of anaemia of chronic disease. Blood Rev 16:87–96

    Article  PubMed  Google Scholar 

Download references

Disclosures

None

Author information

Authors and Affiliations

  1. Children’s Hospital, Helsinki University Central Hospital, University of Helsinki, Helsinki, 00029 HUS, Finland

    Kristiina Aalto, Visa Honkanen & Pekka Lahdenne

Authors
  1. Kristiina Aalto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Visa Honkanen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pekka Lahdenne
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kristiina Aalto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aalto, K., Honkanen, V. & Lahdenne, P. Iron status during anti-TNF therapy in children with juvenile idiopathic arthritis. Clin Rheumatol 30, 115–119 (2011). https://doi.org/10.1007/s10067-010-1571-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-010-1571-7

Keywords

Search

Navigation